Bobshell Electrodes
In the Dec 2024 quarter, revenue was ₹0.19 Cr, against ₹0.41 Cr a year earlier and net profit was −₹0.12 Cr, against −₹0.14 Cr a year earlier (compared with Dec 2023). Promoters held 17.66% of Bobshell Electrodes in Dec 2024, unchanged from Sep 2024.
Peer Comparison
Industrials › Industrial Manufacturing › Industrial Products
| ₹3,915.80 | 96.52 | 46,324 Cr | 14.22 | 0.04% | 19.61% | 25.98% | 4,896 Cr | 477 Cr | |
| ₹1,649.50 | 86.36 | 31,807 Cr | 11.11 | 0.10% | 11.28% | 14.83% | 5,510 Cr | 401 Cr | |
| ₹30,195.00 | 48.44 | 26,697 Cr | 5.72 | 0.35% | 11.76% | 15.68% | 4,959 Cr | 552 Cr | |
| ₹951.90 | 67.32 | 21,648 Cr | 10.82 | 0.00% | 16.79% | 22.04% | 2,236 Cr | 323 Cr | |
| ₹3,211.00 | 62.26 | 21,525 Cr | 4.55 | 0.00% | 7.64% | 12.03% | 4,043 Cr | 345 Cr | |
| ₹16,461.00 | 100.61 | 17,585 Cr | 5.79 | 0.21% | 4.56% | 5.85% | 3,824 Cr | 176 Cr | |
Bobshell Electrodes (this company) | — | — | — | — | — | — | — | 2 Cr | — |
| Median 7 companies | ₹3,563.40 | 76.84 | 24,173 Cr | 8.31 | 0.07% | 11.52% | 15.26% | 4,043 Cr | 373 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 2 companies are not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
5- The company has delivered a poor sales growth of -4.78% over past five years.
- Company has a low return on equity of -5.01% over last 3 years.
- Earnings include an other income of Rs.2.14 Cr.
- Company has high debtors of 256 days.
- Working capital days have increased from 68.4 days to 248 days
Growth Rate
change over 1 year
Quarterly Results
| Particulars | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.24 | 0.87 | 0.47 | 0.38 | 0.61 | 0.66 | 1.65 | 0.29 | 0.41 | 0.64 | 0.73 | 0.71 | 0.19 |
| Expenses | 1.13 | 1.02 | 0.63 | 0.53 | 0.72 | 0.8 | 1.07 | 0.59 | 0.53 | 0.73 | 0.86 | 1.26 | 0.28 |
| Operating Profit | 0.11 | -0.15 | -0.16 | -0.15 | -0.11 | -0.14 | 0.58 | -0.3 | -0.12 | -0.09 | -0.13 | -0.55 | -0.09 |
| OPM % | 8.87% | -17.24% | -34.04% | -39.47% | -18.03% | -21.21% | 35.15% | -103.45% | -29.27% | -14.06% | -17.81% | -77.46% | -47.37% |
| Other Income | 0.02 | 0.02 | 0 | 0.02 | 0 | 0.02 | 0 | 0.03 | 0 | 2.11 | 0 | 0.03 | 0 |
| Interest | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| PBT | 0.1 | -0.15 | -0.2 | -0.17 | -0.14 | -0.15 | 0.54 | -0.3 | -0.14 | 2 | -0.15 | -0.54 | -0.11 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 12% | 0% | -1.85% | 0% |
| Net Profit | 0.11 | -0.15 | -0.2 | -0.16 | -0.14 | -0.15 | 0.54 | -0.29 | -0.14 | 1.75 | -0.15 | -0.54 | -0.12 |
Profit & Loss
| Particulars | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.38 | 2.49 | 3 | 2.67 | 2.87 | 3.82 | 3.42 | 4.05 | 5.11 | 2.11 | 2.99 | 2.27 |
| Expenses | 2.33 | 2.53 | 3.07 | 2.7 | 2.94 | 4.02 | 3.86 | 4.16 | 4.86 | 2.67 | 2.91 | 3.13 |
| Operating Profit | 0.05 | -0.04 | -0.07 | -0.03 | -0.07 | -0.2 | -0.44 | -0.11 | 0.25 | -0.56 | 0.08 | -0.86 |
| OPM % | 2.1% | -1.61% | -2.33% | -1.12% | -2.44% | -5.24% | -12.87% | -2.72% | 4.89% | -26.54% | 2.68% | -37.89% |
| Other Income | 0.06 | 0.06 | 0.08 | 0.09 | 0.08 | 0.09 | 0.06 | 0.04 | 0.04 | 0.04 | 2.13 | 2.14 |
| Interest | 0.01 | 0.01 | 0 | 0.02 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.09 | 0.1 | 0.11 | 0.1 | 0.08 | 0.09 | 0.11 | 0.1 | 0.08 |
| PBT | 0.02 | -0.07 | -0.07 | -0.05 | -0.1 | -0.22 | -0.49 | -0.16 | 0.19 | -0.65 | 2.09 | 1.2 |
| Tax % | 50% | 14.29% | 14.29% | 20% | 0% | 9.09% | -2.04% | 0% | 0% | 0% | 11.48% | — |
| Net Profit | 0 | -0.08 | -0.08 | -0.06 | -0.1 | -0.23 | -0.48 | -0.16 | 0.19 | -0.65 | 1.86 | 0.94 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 |
| Reserves | -2.29 | -2.36 | -2.44 | -2.51 | -2.64 | -2.59 | -3.07 | -3.22 | -3.04 | -3.69 | -1.83 | -2.52 |
| Borrowings | 0.01 | 0.03 | 0 | 0.03 | 0.07 | 0 | 0.05 | 0 | 0.31 | 0.16 | 0 | 0.13 |
| Other Liabilities | 0.34 | 0.3 | 0.28 | 0.23 | 0.33 | 0.36 | 0.24 | 0.26 | 0.27 | 1.27 | 0.48 | 0.26 |
| Total Liabilities | 4.07 | 3.98 | 3.85 | 3.76 | 3.77 | 3.78 | 3.23 | 3.05 | 3.55 | 3.75 | 4.66 | 3.88 |
| Fixed Assets | 1.62 | 1.59 | 1.58 | 1.65 | 1.65 | 1.43 | 1.4 | 1.29 | 1.59 | 1.49 | 0.85 | 0.91 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.45 | 2.39 | 2.27 | 2.11 | 2.12 | 2.35 | 1.83 | 1.76 | 1.96 | 2.26 | 3.81 | 2.97 |
| Total Assets | 4.07 | 3.98 | 3.85 | 3.76 | 3.77 | 3.78 | 3.23 | 3.05 | 3.55 | 3.75 | 4.66 | 3.88 |
Cash Flow
| Particulars | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.23 | -0.25 | 0.67 | 0.02 | 0.06 | — | -0.31 | -0.15 | 0.42 | -0.1 | -1.9 |
| Investing | -0.09 | -0.05 | -0.16 | -0.28 | -0.16 | — | 0.21 | -0.01 | -0.44 | 0 | 2.61 |
| Financing | 0 | 0 | 0 | 0.03 | -0.11 | — | 0 | 0 | 0.31 | 0.08 | -0.39 |
| Net Cash Flow | 0.14 | -0.3 | 0.51 | -0.23 | -0.21 | — | -0.11 | -0.16 | 0.29 | -0.02 | 0.32 |
| Free Cash Flow | 0.17 | -0.31 | 0.61 | -0.14 | -0.1 | — | -0.38 | -0.12 | 0.02 | -0.1 | 0.72 |
| CFO/OP | 460 | 625 | -957 | -67 | -86 | — | 70 | 136 | 168 | 18 | -2,375 |
Ratios
| Particulars | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 166 | 139 | 74.22 | 76.55 | 78.85 | 45.86 | 30.95 | 45.96 | 20.71 | 102 | 256 |
| Inventory Days | 57.9 | 65.18 | 34.07 | 33.91 | 50.93 | 73.78 | 77.14 | 37.55 | 41.37 | 140 | 56.64 |
| Days Payable | 35.24 | 21.73 | 14.6 | 3.99 | 27.59 | 34.95 | 24.46 | 22.53 | 31.63 | 388 | 123 |
| Cash Conversion Cycle | 188 | 183 | 93.68 | 106 | 102 | 84.69 | 83.63 | 60.98 | 30.45 | -146 | 190 |
| Working Capital Days | 173 | 205 | 88.82 | 103 | 95.38 | 57.33 | 59.77 | 53.17 | 21.43 | -64 | 248 |
| ROCE % | — | -1.62% | -1.93% | -0.85% | -2.58% | — | -14.66% | -5.19% | 6.59% | -21.88% | 0.9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bobshell Electrodes insights
28 extracted metrics + investor summaries across FY11–FY25.
Frequently Asked Questions about Bobshell Electrodes
What does Bobshell Electrodes Ltd do?
Which sector does Bobshell Electrodes Ltd belong to?
Company Information
Bobshell Electrodes is engaged in the business of manufacturing of Welding Rods.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/1269453.md for Bobshell Electrodes Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.